Abstract
Aim of the study was to record the prevalence of the various types of viral hepatitis, especially hepatitis B, in pregnant Albanian refugees in Greece. The study comprised 500 pregnant refugees of mean age 25:1 ± 4,6 years. In Albania, all women had lived in overcrowded houses and had been exposed to non throw-away needles and syringes. Various indices for all hepatitis types were determined. The prevalence of HBsAg was 13.4%, of anti-HBs 53%, of total anti-HBc 70.8%, of anti-HBc IgM 0.4%, of HBeAg 1.2%, of anti-HBe 58.6%, of anti-HAV 96.2%, of anti-HAV IgM 1%, of anti-HDV 0.4%, of anti-HCV 0.6% and of anti-HEV 2%. HBeAg was found positive in 7.5% of HBsAg carriers. Prevalence of hepatitis B markers, as determined by HBsAg and/or anti-HBs and/or total anti-HBc was significantly higher in those with a history of previous hospitalization in Albania (p = 0.01) and those with previous history of hepatitis (p = 0.02). The high prevalence of hepatitis B markers in pregnant Albanian refugees proves that HBV infection is highly endemic in Albania and the possibility of perinatal transmission to the offsprings urges for HBV vaccination programmes. On the other hand improvements in the socioeconomic conditions and the sanitation system in Albania is anticipated to reduce the incidence of HAV and HBV infections.
Article PDF
Similar content being viewed by others
References
Donvito M, Quagliara V, Calabrese F. Emergencies in human migrations: Military Medicine in the relief activities during the Albanian exodus. Minerva-Anestesiol 1991; 57: 1511–1515.
Institute of Medicine. New vaccine development-establishing priorities, Vol 2: Diseases of importance in developing countries. Washington: National Academy Press, 1986: 197–222.
Dienstag JL, Szmuness W, Stevens CE, Purcell RH. Hepatitis A virus infection: New insights from seroepidemiologic studies. J Infect Dis 1978; 137: 328–340.
Fay OH, Hadler SC, Maynard JE, Pinheiro F. Hepatitis in the Americas. Bull Pan Am Health Org. 1985; 19: 401–408.
Lemon SM. Type A viral hepatitis: New developments in an old disease. N Eng J Med 1985; 313: 1059–1067.
Mutton KJ, Gust ID. Public health aspects of hepatitis A. In: Gerety RJ (ed), Hepatitis A. Orlando, FL: Academic Press, 1984: 133–161.
Kremastinou J, Kalapothaki V, Trichopoulos D. The changing epidemiologic pattern of hepatitis A infection in urban Greece. Am J Epidemiol 1984; 120: 703–706.
Villarejos VM, Serra CJ, Anderson-Visona K, Mosley JW. Hepatitis A virus infection in households. Am J Epidemiol 1982; 115: 577–586.
Szmuness W, Dienstag JL, Purcell RH, Stevens CE, Wong DC, Ikram H, Bar-Shany S, Beasley RP, Desmyter J, Gaon JA. The prevalence of antibody to hepatitis A antigen in various parts of the world: A pilot study. Am J Epidemiol 1977; 106: 392–398.
Chadwick RG, Hall AJ, Davidson I, Bull FG, Wright R. Hepatitis B among Indochinese refugees in Great Britain. Postgrad Med J 1982; 58: 676–679.
Skinhoj P, Aldershvile J, Kjersem M, Black F. Hepatitis B infection in Vietnamese families. J Med Virol 1983; 11: 125–129.
Nicholls ES, Chaudhary RK, Kennedy DA, Jung J, Davies JW, Gill P. Hepatitis B follow-up among Indochinese refugees. Can Med Assoc J 1984; 131: 1073–1076.
Goldstein GB, Reid JC, Keo L. A review of refugee medical screening in New South Wales. Med J Aust 1987; 146: 9–12.
Franks AL, Berg CJ, Kane MA, Browne BB, Sikes RK, Elsea WR, Burton AH. Hepatitis B virus infection among children born in the United States to Southeast Asian refugees. N Engl J Med 1989; 321: 1301–1305.
Hurie MB, Mast EE, Davis JP. Horizontal transmission of hepatitis B virus infection to United States-born children of Hmong refugees. Pediatrics 1992; 89: 269–273.
Hollinger FB, Dienstag JL. (1985): Hepatitis viruses. In: Lennettc A, Balows WH, Hausler JR, Shadomy HJ (eds), Manual of clinical microbiology, 4th ed. Washington: American Society of Microbiology, 1985: 813–835.
Maynard JE. Hepatitis B vaccine: Strategies for utilization, In: Maupas P, Guesry P (eds), Hepatitis B vaccine. INSERM Symposium No. 18. Amsterdam: Elsevier/North Holland Biomedical Press, 1981: 13–19.
Sobeslavsky O. Prevalence and markers of hepatitis B infection in various countries. A WHO collaborative study. Bull WHO 1980; 58: 621–628.
Murray-Lyon IM. Strategies for preventing hepatitis B. Quart J Med 1989; 71: 277–278.
Centers for Disease Control. Hepatitis Surveillance Report No 51, CDC, Atlanta 1987.
Chen DS, Lai MY, Lee SC, Yang PN, Sheu JC, Sung JL. Serum HBeAg, HBeAg, anti-HBe and hepatitis B viral DNA in asymptomatic carriers in Taiwan. J Med Virol 1985; 19: 87–94.
Stevens CE, Neurath RA, Beasley RP, Szmuness W. HBeAg and anti-HBe detection by radioimmunoassay: Correlation of vertical transmission of hepatitis B virus in Taiwan. J Med Virol 1979; 3: 237–241.
Chan KH, Hargie MP, Decker RH, Mushahwar IK, Overby LR. Serodiagnosis of recent hepatitis B infection by IgM class anti-HBc. Hepatology 1983; 3: 142–149.
Hadler SC, Margolis HS. Viral Hepatitis. In: Alfred S. Evans (ed), Viral infections of humans-epidemiology and control, 3rd ed. New York-London: Plenum Medical Book Company, 1989: 351–391.
Rizzetto M. The delta antigen. Hepatology 1983; 3: 729–737.
Ponzetto A, Forzani B, Parravicini PP, Hele C, Zanetti A, Rizzettc M. Epidemiology of delta virus infection. Eur J Epidemiol 1986; 1: 257–263.
Hoofnagle JH. Type D (delta) hepatitis. JAMA 1989; 261:1321–1325.
Lynch-Salamon DI, Combs CA. Hepatitis C in obstetrics and gynecology. Obstet Gynecol 1992; 79: 621–629.
Weinstock HS, Bolan G, Reingold AL, Polish LB. Hepatitis C virus infection among patients attending a clinic for sexually transmitted diseases. JAMA 1993; 269:392–394.
Osmond DH, Padian NS, Sheppard HW, Glass S, Shiboski SC, Reingold A. Risk factors for hepatitis C virus seropositivity in heterosexual couples. JAMA 1993; 269: 361–365.
Thomas DL, Mahley RW, Badur S, Palaoglu KE, Quinn TC. Epidemiology of hepatitis E virus infection in Turkey. Lancet 1993; 341: 1561–1562.
Favorov MO, Fields HA, Purdy MA, Yashina TL, Aleksandrov AG, Alter MJ, Yarasheva DM, Bradley DW, Margolis HS. Serologic identification of hepatitis E virus infections in epidemic and endemic settings. J Med Virol 1992; 36: 246–250.
Simms J, Duff P. Viral hepatitis in pregnancy. Seminars in Perinatology, 1993; 17: 384–393.
Sweet RL. Hepatitis B infection in pregnancy. Obstet Gynecol Report 1990; 2: 128–139.
Beasley RP, Huang LY, Stevens CE, Lin CC, Cahsieb FJ, Wang KJ, Sun TS, Szmuness W. Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B carrier state: Final report of a randomized double-blind placebo-controlled trial. Hepatology 1983; 3: 135–141.
Stevens CE, Taylor PE, Tong MJ, Toy PT, Yvas GN, Nair EV, Weisman JY, Krugman S. Yeast recombinant hepatitis B vaccine: Efficacy with hepatitis immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA 1987; 257: 2612–2616.
Centers for Disease Control. Protection against viral hepatitis. Recommendations of the Immunazation Practices Advisory Committee. MMWR 1990; 39 (RR-2): 1–26.
Jefferson T, Demicheli V. Is vaccination against hepatitis B efficient? A review of world literature. Health Econ 1994; 3: 25–37.
Bloom BS, Hillman AL, Fendrick AM, Schwartz JS. A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis. Ann Intern Med 1993; 118: 298–306.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Malarnitsi-Puchner, A., Papacharitonos, S., Sotos, D. et al. Prevalence study of different hepatitis markers among pregnant Albanian refugees in Greece. Eur J Epidemiol 12, 297–301 (1996). https://doi.org/10.1007/BF00145420
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00145420